MAPT and Alzheimer disease: Pathologically, AD is characterized by severe neuronal loss, aggregation of amyloid-β (Aβ) in extracellular senile plaques, and formation of intraneuronal neurofibrillary tangles consisting of hyperphosphorylated tau (p-tau) protein whose levels can be measured in the cerebrospinal fluid (CSF).